See more : HB Portfolio Limited (HBPOR.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Procter & Gamble Health Limited (PGHL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Procter & Gamble Health Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Carlsberg A/S (CABHF) Income Statement Analysis – Financial Results
- Ecoclime Group AB (publ) (ECC-B.ST) Income Statement Analysis – Financial Results
- Skyline Champion Corporation (SKY) Income Statement Analysis – Financial Results
- First Community Financial Corporation (FMFP) Income Statement Analysis – Financial Results
- Supernus Pharmaceuticals, Inc. (0LB2.L) Income Statement Analysis – Financial Results
Procter & Gamble Health Limited (PGHL.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.pghealthindia.com
About Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.51B | 12.30B | 10.92B | 9.91B | 9.03B | 8.49B | 11.04B | 9.93B | 9.38B | 8.63B | 7.94B | 6.56B | 5.58B | 5.09B | 4.73B | 3.89B | 3.15B |
| Cost of Revenue | 3.31B | 3.62B | 3.67B | 3.39B | 5.02B | 2.71B | 4.45B | 4.17B | 4.52B | 4.16B | 3.81B | 3.02B | 2.43B | 2.08B | 2.06B | 1.60B | 1.26B |
| Gross Profit | 8.21B | 8.68B | 7.25B | 6.52B | 4.02B | 5.78B | 6.58B | 5.76B | 4.85B | 4.46B | 4.13B | 3.54B | 3.15B | 3.01B | 2.67B | 2.29B | 1.88B |
| Gross Profit Ratio | 71.29% | 70.57% | 66.38% | 65.76% | 44.47% | 68.04% | 59.65% | 58.02% | 51.76% | 51.73% | 52.07% | 53.99% | 56.46% | 59.17% | 56.44% | 58.92% | 59.82% |
| Research & Development | 0.00 | 57.10M | 65.50M | 39.30M | 57.27M | 20.50M | 29.50M | 154.60M | 121.10M | 110.40M | 86.20M | 50.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.48B | 233.20M | 474.30M | 728.34M | 298.90M | 437.70M | 382.50M | 291.00M | 311.50M | 315.00M | 267.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 744.90M | 1.09B | 864.30M | 1.19B | 999.10M | 933.70M | 669.40M | 728.50M | 634.20M | 587.90M | 447.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.14B | 2.23B | 1.33B | 1.34B | 1.92B | 1.30B | 1.37B | 1.05B | 1.02B | 945.70M | 902.90M | 714.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 183.90M | 2.89B | 2.94B | -73.93M | -489.50M | -498.30M | -307.80M | 5.50M | 5.60M | 5.10M | -205.30M | 2.19B | 2.05B | 1.71B | 1.38B | 884.70M |
| Operating Expenses | 2.14B | 5.72B | 4.29B | 4.32B | 2.05B | 4.00B | 4.73B | 4.52B | 4.21B | 4.00B | 3.45B | 2.36B | 2.19B | 2.05B | 1.71B | 1.38B | 884.70M |
| Cost & Expenses | 5.44B | 9.34B | 7.96B | 7.71B | 7.07B | 6.71B | 9.18B | 8.68B | 8.74B | 8.16B | 7.26B | 5.38B | 4.62B | 4.13B | 3.77B | 2.98B | 2.15B |
| Interest Income | 0.00 | 0.00 | 98.80M | 150.60M | 572.50M | 171.90M | 178.90M | 177.20M | 154.70M | 164.80M | 181.40M | 172.40M | 145.60M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.20M | 7.70M | 4.20M | 8.00M | 0.00 | 0.00 | 402.30M | 200.70M | 0.00 | 0.00 | 0.00 | 19.10M | 200.00K | 700.00K | 300.00K | 100.00K | 100.00K |
| Depreciation & Amortization | 274.00M | 277.50M | 267.30M | 296.90M | 192.87M | 209.40M | 191.20M | 248.10M | 234.20M | 126.80M | 100.70M | 89.00M | 79.50M | 71.00M | 75.10M | 57.30M | 65.90M |
| EBITDA | 3.07B | 3.43B | 2.81B | 2.64B | 2.09B | 1.96B | 2.19B | 1.57B | 887.20M | 595.70M | 792.90M | 1.28B | 1.04B | 1.17B | 1.04B | 974.80M | 1.06B |
| EBITDA Ratio | 26.70% | 27.84% | 26.32% | 26.75% | 23.92% | 23.11% | 19.82% | 15.90% | 9.46% | 6.90% | 9.99% | 19.44% | 18.57% | 23.01% | 21.98% | 25.03% | 33.82% |
| Operating Income | 6.07B | 3.14B | 2.60B | 2.35B | 1.97B | 1.71B | 1.92B | 1.30B | 653.00M | 468.90M | 692.20M | 1.19B | 956.10M | 1.10B | 964.80M | 917.50M | 998.70M |
| Operating Income Ratio | 52.72% | 25.56% | 23.84% | 23.72% | 21.79% | 20.17% | 17.43% | 13.13% | 6.96% | 5.43% | 8.72% | 18.08% | 17.15% | 21.62% | 20.39% | 23.56% | 31.72% |
| Total Other Income/Expenses | -3.34B | -2.45B | -2.24B | -2.04B | 397.27M | -1.57B | -303.70M | -168.20M | -159.70M | 196.70M | 190.30M | -19.10M | -200.00K | -700.00K | -300.00K | -100.00K | -100.00K |
| Income Before Tax | 2.73B | 3.14B | 2.53B | 2.33B | 2.37B | 1.58B | 1.52B | 1.10B | 833.30M | 665.60M | 882.50M | 1.17B | 955.90M | 957.10M | 964.50M | 917.40M | 998.60M |
| Income Before Tax Ratio | 23.74% | 25.55% | 23.20% | 23.54% | 26.19% | 18.61% | 13.79% | 11.10% | 8.89% | 7.71% | 11.12% | 17.79% | 17.14% | 18.80% | 20.39% | 23.56% | 31.72% |
| Income Tax Expense | 723.40M | 847.30M | 608.50M | 564.80M | 671.80M | 562.50M | 582.80M | 343.30M | 297.70M | 233.40M | 323.70M | 383.90M | 319.10M | 325.30M | 309.70M | 287.30M | 310.40M |
| Net Income | 2.01B | 2.29B | 1.93B | 1.77B | 1.69B | 8.39B | 939.10M | 758.90M | 535.60M | 432.20M | 558.80M | 784.00M | 636.80M | 631.80M | 654.80M | 630.10M | 688.20M |
| Net Income Ratio | 17.46% | 18.66% | 17.63% | 17.84% | 18.75% | 98.79% | 8.51% | 7.65% | 5.71% | 5.01% | 7.04% | 11.94% | 11.42% | 12.41% | 13.84% | 16.18% | 21.86% |
| EPS | 121.07 | 138.24 | 115.98 | 106.51 | 102.04 | 505.27 | 56.57 | 45.72 | 32.30 | 26.00 | 33.70 | 47.20 | 38.40 | 38.10 | 39.00 | 37.40 | 40.80 |
| EPS Diluted | 121.07 | 138.24 | 115.98 | 106.51 | 102.04 | 505.27 | 56.57 | 45.72 | 32.30 | 26.00 | 33.70 | 47.20 | 38.40 | 38.10 | 39.00 | 37.40 | 40.80 |
| Weighted Avg Shares Out | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.77M | 16.86M | 16.86M |
| Weighted Avg Shares Out (Dil) | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.77M | 16.86M | 16.86M |
Source: https://incomestatements.info
Category: Stock Reports